Paracetamol
- Common uses
- Mild to moderate pain; fever
- Key risks & cautions
- Liver injury, especially with overdose or duplicate products
The nursing study shelf
Get to know the class, the purpose and the key risks. A little more understanding, one medicine at a time.
No matching medicines. Try a shorter name or choose another topic.
Australian contextSpecialist context: retained from the original learning list, including use in selected tuberculosis regimens. Not a routine Australian first-choice antibiotic.
Australian contextAustralian context: carbimazole is used in Australia, but it is a different medicine - not simply another name for thiamazole. Check the actual product.
Australian contextPrednisone and prednisolone are distinct medicines. Do not treat their names as interchangeable.
Australian contextCalcium gluconate protects the heart in severe hyperkalaemia; it does not lower potassium.
Australian contextZyban SR is approved in Australia for smoking cessation. Depression treatment is off-label.
Australian contextMDD means major depressive disorder. Selected extended-release products have this indication; check the product information.
Australian names are used here, including paracetamol, salbutamol, adrenaline, noradrenaline and glyceryl trinitrate. Search also recognises several overseas names. Specialist or non-routine entries from the original study list are clearly labelled.
These cards do not cover every interaction, contraindication or monitoring requirement. Formulation and route can change a medicine's uses and risks. Do not start, stop or change medicines using this page. No dosage recommendations are provided.
AF: atrial fibrillation
DVT / PE: deep vein thrombosis / pulmonary embolism
DKA: diabetic ketoacidosis
COPD: chronic obstructive pulmonary disease
OCD: obsessive-compulsive disorder
MDD: major depressive disorder
XR: extended release
NSAID: non-steroidal anti-inflammatory drug
SSRI: selective serotonin reuptake inhibitor
SNRI: serotonin-noradrenaline reuptake inhibitor
NDRI: noradrenaline-dopamine reuptake inhibitor
STEMI: ST-elevation myocardial infarction
QT prolongation: delayed electrical recovery of the heart, increasing arrhythmia risk
PDE5 inhibitors: medicines such as sildenafil; unsafe with nitrates
ACE: angiotensin-converting enzyme
NMDA: N-methyl-D-aspartate receptor
SGLT2: sodium-glucose co-transporter 2
GLP-1: glucagon-like peptide-1
Adapted from the Australian Medicines Cartoon Study Guide. Australian naming and priority safety corrections were checked against public Australian sources. Independent AI reviews checked content and presentation; this is not pharmacist certification or an exhaustive review of every product. Local clinical review is recommended before institutional use.
Content prepared 3 October 2026. April font by Gaelleing.